- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Roche challenged two GSK corporate press releases about lapatinib (Tykerb/Tyverb). The Panel found one release misleading on adverse event/risk-benefit balance, but rejected…
Cephalon challenged ProStrakan leavepieces claiming Abstral provided rapid relief from 10 minutes. The Panel found the claim inconsistent with the Abstral SPC,…
A MASTA rep sent an unapproved promotional email about Epaxal without prescribing info. Follow-up “training” pointed staff to an out-of-date Code and…
Complaint said an Ezetrol Pulse ad implying “New NICE” guidance was misleading vs NICE lipid guideline. Panel found headline clearly referred to…
A nurse challenged a Ferinject detail aid as inaccurate. The PMCPA found the CosmoFer administration chart and “Single dose delivery” messaging on…
Merz promoted Xeomin as “At least as effective as Botox with a similar safety profile” on an exhibition panel. PMCPA ruled the…
Novartis’ Zometa leavepiece was ruled misleading: an ambiguous strapline implied prevention of bone metastases; a modified forest plot invited unfair comparisons; oral…
A cardiology professor said a Cozaar journal ad downplayed beta‑blocker cautions in heart failure. Panel found the ad aligned with the SPC…
A doctor alleged a GSK-sponsored BPH supplement failed to disclose Prostate UK’s other GSK funding. The Panel held the sponsorship declaration was…
Anonymous complaint alleged Roche paid a chemist chain £100k/year to drive Xenical prescribing via PGDs. Panel found a one-off £100k payment existed…
Anonymous alleged an AstraZeneca meeting misled attendees and promoted Seroquel for borderline personality disorder. Panel found no evidence of off-label promotion or…
Anonymous practice nurses alleged nuisance visits and joint promotion with a devices rep. Panel found insufficient evidence on balance of probabilities and…
A doctor alleged an HSJ stroke “Special Report” sponsored by Boehringer resembled independent editorial matter (disguised promotion). Panel and Appeal Board found…
Complaint alleged GSK’s public website promoted POMs (incl. Nucala) and a patient-gate pop-up misdirected non-patients to patient content. Panel found insufficient evidence…
Ex-employee alleged an RBM pushed sales staff to pressure prescribers using medico-legal “you might be sued” messaging for Latuda. Panel found RBM…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.